Literature DB >> 21857157

Characterization of human melanoma cell lines and melanocytes by proteome analysis.

Emilia Caputo1, Luigi Maiorana, Valeria Vasta, Franca M Pezzino, Sudhir Sunkara, Kieran Wynne, Giuliano Elia, Francesco M Marincola, James A McCubrey, Massimo Libra, Salvatore Travali, Marian Kane.   

Abstract

We have analyzed the proteomes of two human melanoma cell lines (A375 and 526), and of the human melanocytes, (FOM 78), by two-dimensional electrophoresis (2D-PAGE) and liquid chromatography - tandem mass spectrometry (LC-MS/MS). Our comparative proteomic analysis revealed that six proteins were over-expressed in both melanoma cell lines as compared to melanocytes: galectin-1, inosine-5'-monophosphate dehydrogenase 2, serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform, protein DJ-1, cyclophilin A and cofilin-1. We show, for the first time, that only specific isoforms of these molecules are over-expressed in melanoma. Different protein profiles were also found between each individual melanoma cell line and the melanocytes. s-Methyl-5-thioadenosine phosphorylase, ubiquitin and ribosomal protein S27 a precursor, the basic form of protein DJ-1, annexin a1, proliferation associated protein 2g4, isoform alfa-enolase of alfa-enolase, protein disulfide-isomerase precursor, and elongation factor 2 were more strongly expressed in A375 cells compared to melanocytes. In 526 cells, 60s acidic ribosomal protein p1 and calreticulin precursor were more highly expressed than in melanocytes. These molecular differences may help in better understanding melanoma development and its different responsiveness to therapies. The identified proteins could be exploited as biomarkers or therapeutic targets for melanoma.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857157      PMCID: PMC5479465          DOI: 10.4161/cc.10.17.17068

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  Rapid and deep human proteome analysis by single-dimension shotgun proteomics.

Authors:  Mohammad Pirmoradian; Harshavardhan Budamgunta; Konstantin Chingin; Bo Zhang; Juan Astorga-Wells; Roman A Zubarev
Journal:  Mol Cell Proteomics       Date:  2013-07-22       Impact factor: 5.911

Review 2.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

3.  Rapid Noninvasive Skin Monitoring by Surface Mass Recording and Data Learning.

Authors:  Yingdi Zhu; Andreas Lesch; Xiaoyun Li; Tzu-En Lin; Natalia Gasilova; Milica Jović; Horst Matthias Pick; Ping-Chih Ho; Hubert H Girault
Journal:  JACS Au       Date:  2021-03-22

4.  High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients.

Authors:  Takahiko Kawate; Keiichi Iwaya; Kayoko Koshikawa; Tomoyuki Moriya; Tamio Yamasaki; Sho Hasegawa; Hiroshi Kaise; Tomoyuki Fujita; Hirotaka Matsuo; Takahiro Nakamura; Takashi Ishikawa; Sadayuki Hiroi; Sanae M M Iguchi-Ariga; Hiroyoshi Ariga; Keiichi Murota; Minoru Fujimori; Junji Yamamoto; Osamu Matsubara; Norio Kohno
Journal:  Cancer Sci       Date:  2015-05-06       Impact factor: 6.716

5.  Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer.

Authors:  Carolina Beatriz Müller; Marco Antônio De Bastiani; Matheus Becker; Fernanda Stapenhorst França; Mariane Araujo Branco; Mauro Antônio Alves Castro; Fabio Klamt
Journal:  Oncotarget       Date:  2015-02-28

6.  Cofilin-1 levels and intracellular localization are associated with melanoma prognosis in a cohort of patients.

Authors:  Candelaria Bracalente; Adriana R Rinflerch; Irene L Ibañez; Francisco M García; Victoria Volonteri; Gastón N Galimberti; Fabio Klamt; Hebe Durán
Journal:  Oncotarget       Date:  2018-05-08

7.  IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.

Authors:  Shiyu Duan; Wenqing Huang; Xiaoting Liu; Xuming Liu; Nana Chen; Qiong Xu; Yukun Hu; Wen Song; Jun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2018-12-05

8.  A Critical Role of Peptidylprolyl Isomerase A Pseudogene 22/microRNA-197-3p/Peptidylprolyl Isomerase A Axis in Hepatocellular Carcinoma.

Authors:  Yuwei Gu; Chao Wang; Shengsen Chen; Jia Tang; Xiaoxiao Guo; Wei Hu; An Cui; Dian Zhang; Kangkang Yu; Mingquan Chen
Journal:  Front Genet       Date:  2021-03-15       Impact factor: 4.599

Review 9.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10

10.  Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.

Authors:  Magdalena Surman; Sylwia Kędracka-Krok; Dorota Hoja-Łukowicz; Urszula Jankowska; Anna Drożdż; Ewa Ł Stępień; Małgorzata Przybyło
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.